References
- Somjen D, Weisman Y, Harell A, et al. Direct and sex specific stimulation by sex steroids of creatine kinase activity and DNA synthesis in rat bone. Proc Natl Acad Sci USA 1989;86:3361-3
- Kaye AM, Weisman Y, Harell A, Somjen D. Hormonal stimulation of bone cell proliferation. J Steroid Biochem Mol Biol 1990;37:431-5
- Reiss N, Kaye AM. Identification of the major component of the estrogen induced protein of rat uterus as the BB isozyme of creatine kinase. J Biol Chem 1981;256:5741-5
- Fournier B, Haring S, Kaye AM, Somjen D. Stimulation of creatine kinase specific activity in human osteoblast and endometrial cells by estrogens and anti-estrogens and its modulation by calciotropic hormones. J Endocrinol 1996;50:275-81
- Eriksen EF, Colard DS, Berg NJ. Graham, ML, Mann KG, Spelsberg TC, Riggs BL. Evidence of estrogen receptors in normal human osteoblast- like cells. Science 1988;241:84-6
- Komm BS, Terpening CM, Benz DJ, et al. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 1988;241:81-4
- Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res 2002;57:385-409
- Enmark E, Gustafsson JA. Oestrogen receptors. J Intern Med 1999;246:133-8
- Delmas PD. Treatment of postmenopausal osteoporosis. Lancet 2002;359:2018-26
- Katzburg S, Ornoy A, Hendel D, et al. Age and gender specific stimulation of creatine kinase specific activity by gonadal steroids in human bone-derived cells in culture. J Endocrinol Invest 2001;24:166-72
- Eriksen E F, Glerup H. Vitamin D deficiency and aging: implications for general health and osteoporosis. Biogerontology 2002;3:73-7
- Somjen D, Waisman A, Weisman Y, Kaye AM. Non-hypercalcemic analogs of 1α, 25 dihydroxy vitamin D augment the induction of creatine kinase B by estrogen and selective estrogen receptor modulators (SERMS) in osteoblast-like cells and rat skeletal organs. J Steroid Biochem Mol Biol 2000;72:79-88
- Somjen D, Harell A, Jaccard N, et al. Reciprocal modulation by sex steroids and calciotropic hormones of skeletal cell proliferation. J Steroid Biochem Mol Biol 1990;37:491-9
- Posner GH, Lee JK, Wang Q, et al. Noncalcemic, antiproliferative, transcriptionally active, 24-fluorinated hybrid analogues of the hormone 1α, 25-dihydroxyvitamin D3. Synthesis and preliminary biological evaluation. J Med Chem 1998;41:3008-14
- Katzburg S, Hendel D, Waisman A, et al. Treatment with non-hypercalcemic analogs of 1,25 dihydroxy vitamin D3 increases responsiveness to 17-β estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts. J Steroid Biochem Mol Biol 2005;88:213-19
- Somjen D, Katzburg S, Stern N, et al. 25 Hydroxy-vitamin D3-1α hydroxylase expression and activity in cultured human osteoblasts and their modulation by parathyroid hormone, estrogenic compounds and dihydrotestosterone. J Steroid Biochem Mol Biol 2007;107:238-44
- Somjen D, Katzburg S, Sharon O, et al. Modulation of response to estrogens in cultured human female bone cells by a non-calcemic vitamin D analog: changes in nuclear and membrane binding. J Steroid Biochem Mol Biol 2004;89-90.393-5
- Feldman D, Malloy PJ, Goldschmidt D, Gross C. Vitamin D: biology, action and clinical implications. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. Volume 1. Academic Press; San Diego, CA, USA: 2001. p. 230-57